ArticleEuropean heart journal open2022

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register.

Maria Concetta Pastore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.